Store Site
Monday, December 6, 2010
ARIAD’s Ponatinib Shows Clinical Evidence Of Improving Anti-Leukemic Activity In Patients With Drug-Resistant CML
http://ping.fm/8UWS6
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment